![Mary Janatpour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Janatpour
Technik-/Wissenschafts-/F&E-Leiter bei
APTEVO THERAPEUTICS INC.
Profil
Mary J.
Janatpour is currently the Director at Active Motif, Inc. since 2021.
Dr. Janatpour is also the Chief Scientific Officer & Senior Vice President at Aptevo Therapeutics, Inc. starting in 2026.
Dr. Janatpour earned a doctorate from The University of California, San Francisco.
Aktive Positionen von Mary Janatpour
| Unternehmen | Position | Beginn |
|---|---|---|
| APTEVO THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.05.2026 |
Active Motif, Inc.
 Active Motif, Inc. BiotechnologyHealth Technology Develops and distributes molecular biology-based research tools and kits | Direktor/Vorstandsmitglied | 01.04.2021 |
Ausbildung von Mary Janatpour
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Active Motif, Inc.
Active Motif, Inc. BiotechnologyHealth Technology Develops and distributes molecular biology-based research tools and kits | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
